Market Overview - The Shanghai Composite Index closed at 3299.76 points, above the annual line, with a change of 0.25% [1] - The total trading volume of A-shares reached 1,121.207 billion yuan [1] Stocks Breaking Annual Line - A total of 106 A-shares have broken above the annual line today [1] - Notable stocks with significant deviation rates include: - Youbuxun: 17.49% deviation, closing price at 15.18 yuan, with a daily increase of 20.00% and turnover rate of 6.57% [1] - Fujilai: 14.53% deviation, closing price at 29.09 yuan, with a daily increase of 20.01% and turnover rate of 30.40% [1] - Chongqing Construction: 8.33% deviation, closing price at 3.01 yuan, with a daily increase of 9.85% and turnover rate of 2.93% [1] Additional Stocks with Minor Deviations - Jiangxi Copper, Meirya, and Laimu Co. have just crossed the annual line with smaller deviation rates [1] - Other stocks with notable performance include: - Changjiang Investment: 7.98% deviation, closing price at 8.01 yuan, with a daily increase of 10.03% [1] - Qingtang City: 7.70% deviation, closing price at 3.78 yuan, with a daily increase of 9.88% [1] - Shenchuan A: 7.45% deviation, closing price at 6.75 yuan, with a daily increase of 9.93% [1] Summary of Stocks with Deviation Rates - A detailed table lists various stocks, their daily change percentages, turnover rates, annual line prices, latest prices, and deviation rates, highlighting the performance of stocks like: - Dongjiang Environmental: 3.70% deviation, closing price at 4.28 yuan, with a daily increase of 10.03% [1] - Feinan Resources: 3.56% deviation, closing price at 19.88 yuan, with a daily increase of 3.92% [1] - The table provides a comprehensive view of the market dynamics and stock performances on the day [2]

Group 1: Company Performance and Financials - The company achieved operating revenue of ¥2,422,198,069.32, a year-on-year increase of 1.35% [4] - The net profit attributable to shareholders was ¥11,721,037.33, a significant decline of 93.88% compared to the previous year [4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥24,498,601.05, down 89.02% year-on-year [4] Group 2: Future Growth Drivers - Future profit growth will be driven by factors such as increased demand for traditional green and environmentally friendly products, continuous process upgrades, and new project construction at production bases [1] - The company aims to expand its international market presence through "going global" strategies [1] Group 3: Industry Trends and Challenges - The pesticide industry is expected to transform towards greening, intelligence, and globalization, with a growing demand for high-efficiency, low-toxicity biopesticides [2] - The industry is experiencing structural changes due to international agricultural market fluctuations and stricter environmental policies [3] Group 4: Impact of External Factors - The company exports a low percentage of its products to the U.S., thus the impact of the U.S.-China tariff war is expected to be limited [2] - The company faces risks from raw material price fluctuations, environmental protection regulations, and safety production risks [8][9] Group 5: Product Development and Innovation - The company is focusing on the development of innovative pesticides, including FG001 and FG201, which are expected to have significant market potential [5][6] - FG001 is designed to effectively control major weeds in rice fields, while FG201 is a novel SDHI fungicide with a broad spectrum of efficacy [6] Group 6: Market Expansion and Risk Management - The company is committed to optimizing procurement management to mitigate risks associated with raw material supply and price volatility [8] - Measures are in place to manage exchange rate risks due to a significant portion of sales being denominated in U.S. dollars [9]

Summary of Conference Call Records Company and Industry Overview - The conference call discusses a company in the agricultural chemicals industry, specifically focusing on the production and sales of pesticides and herbicides. The company is navigating changes in sales models and production capacity for the year 2024 and beyond. Key Points and Arguments Financial Performance - The company reported a significant decrease in cash flow from operating activities, with amounts of 575 million and 643 million for the third and fourth quarters respectively, attributed to changes in sales models and increased domestic sales [1][1][1] - The profit contributions by quarter were as follows: Q1 showed a loss, Q2 contributed over 50 million in net profit, Q3 had a loss of over 14 million, and Q4 reported a loss of 4 million [1][1][1] - The overall sales cost and financial situation for 2024 are expected to remain stable, with no significant changes anticipated [3][3][3] Production Capacity and Utilization - The company has a production capacity utilization rate of 74.34% for raw materials and intermediates, and 84% for technical products, indicating a healthy production environment [2][2][2] - New projects are underway, including the expansion of production capacity for various products, which are expected to be completed by 2025 and 2026 [3][3][3] Research and Development - Continuous investment in R&D is emphasized, particularly in new textile drugs and innovative pharmaceuticals, with expectations of launching promising products in the future [4][4][4] - The company is focusing on developing new herbicides and has plans for multiple product launches in the coming years [6][6][6] Market Position and Pricing Strategy - The company holds a significant market share but is cautious about pricing strategies, indicating that the timing for price adjustments has not yet arrived [2][2][2] - The pricing environment is expected to stabilize, with indications that 2025 will be a more positive year compared to 2024 [8][8][8] Future Outlook - The company anticipates that 2025 will see improved performance compared to 2024, with expectations of higher production and sales volumes [5][5][5] - The introduction of new products and the stabilization of prices are expected to enhance profitability and market position [14][14][14] - The company is also exploring international markets and aims to expand its product offerings beyond domestic markets [26][26][26] Challenges and Risks - The company faces challenges related to fluctuating raw material prices and the need for regulatory approvals for new products, which may impact timelines for product launches [24][24][24] - There is a recognition of the competitive landscape in the agricultural chemicals sector, with a focus on maintaining quality and innovation to differentiate from competitors [9][9][9] Additional Important Content - The company is committed to a "second entrepreneurship" strategy aimed at achieving high growth rates and enhancing shareholder returns [17][17][17] - The management acknowledges the importance of effective communication with investors and stakeholders to build trust and transparency [27][27][27] This summary encapsulates the key insights from the conference call, highlighting the company's current performance, strategic initiatives, and future outlook within the agricultural chemicals industry.

证券代码：300575 证券简称：中旗股份 公告编号：2025-015 江苏中旗科技股份有限公司 关于 2024 年度股东大会增加临时提案暨股东大会补充通知的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 经江苏中旗科技股份有限公司（以下简称"公司"）第四届董事会第五次会议审议通 过，公司决定于 2025 年 4 月 29 日召开 2024 年度股东大会。具体内容详见公司于 2025 年 3 月 31 日在巨潮资讯网（www.cninfo.com.cn）披露的《关于召开 2024 年度股东大会 通知的公告》。 2025 年 4 月 11 日，公司第四届董事会第六次会议审议通过了《公司 2025 年限制性 股票激励计划（草案）及摘要的议案》《公司 2025 年限制性股票激励计划实施考核管理 办法的议案》以及《关于提请股东大会授权董事会办理公司 2025 年限制性股票激励计划 有关事项的议案》，此议案尚需提请公司股东大会审议。为提高决策效率，持有公司 3% 以上股份的股东吴耀军先生于 2025 年 4 月 11 日向公司董事会提交了《关于提请 2024 年 ...

证券代码：300575 证券简称：中旗股份 公告编号：2025-014 江苏中旗科技股份有限公司 第四届监事会第五次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、监事会会议召开情况 本议案尚需提交 2024 年度股东大会审议，并经出席股东大会的股东所持表决权的 三分之二以上通过。 2、审议通过《江苏中旗科技股份有限公司 2025 年限制性股票激励计划实施考核 管理办法的议案》 为了保证公司 2025 年限制性股票激励计划的顺利实施，进一步完善公司法人治理 结构，建立和完善公司激励约束机制，保证激励计划的顺利实施，并在最大程度上发 挥股权激励的作用，进而确保公司发展战略和经营目标的实现。依据有关法律、法规、 规章和规范性文件以及《公司章程》的规定，结合公司实际情况制定了《江苏中旗科 技股份有限公司 2025 年限制性股票激励计划实施考核管理办法》。 《江苏中旗科技股份有限公司 2025 年限制性股票激励计划实施考核管理办法》详 见公司在中国证监会指定创业板信息披露网站巨潮资讯网发布的公告。 江苏中旗科技股份有限公司（以下简称"公司"）第四届监 ...

证券代码：300575 证券简称：中旗股份 公告编号：2025-013 江苏中旗科技股份有限公司 第四届董事会第六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、董事会会议召开情况 《江苏中旗科技股份有限公司 2025 年限制性股票激励计划实施考核管理办法》详 见公司在中国证监会指定创业板信息披露网站巨潮资讯网发布的公告。 江苏中旗科技股份有限公司（以下简称"公司"）第四届董事会第六次会议于 2025 年 4 月 11 日在南京市玄武区徐庄软件园苏园路 6 号 2 栋会议室召开，以现场及通讯表 决相结合的方式召开，会议应出席董事 5 人，实际出席董事 5 人。会议由董事长吴耀军 先生主持，公司监事和高级管理人员列席会议。会议通知已于 2025 年 3 月 28 日以电话 通知及电子邮件的方式向全体董事、监事及高级管理人员送达。本次董事会会议的召开 符合《中华人民共和国公司法》（以下简称"《公司法》"）和《江苏中旗科技股份有限 公司章程》（以下简称"《公司章程》"）的有关规定，会议合法、有效。 二、董事会会议审议情况 1、审议通过《江苏中旗科 ...

江苏中旗科技股份有限公司 2025 年限制性股票激励计划自查表 公司简称：中旗股份 股票代码：300575 | 序号 | 事项 | 是否存在该 | | | --- | --- | --- | --- | | | | 事项（是/否/ | 备注 | | | | 不适用） | | | | 上市公司合规性要求 | | | | 1 | 最近一个会计年度财务会计报告是否被注册会计师出具否定意 | 否 | | | | 见或者无法表示意见的审计报告 | | | | 2 | 最近一个会计年度财务报告内部控制被注册会计师出具否定意 | 否 | | | | 见或者无法表示意见的审计报告 | | | | 3 | 上市后最近 36 个月内出现过未按法律法规、公司章程、公开承 | 否 | | | | 诺进行利润分配的情形 | | | | 4 | 是否存在其他不适宜实施股权激励的情形 | 否 | | | 5 | 是否已经建立绩效考核体系和考核办法 | 是 | | | 6 | 是否为激励对象提供贷款以及其他任何形式的财务资助 | 否 | | | | 激励对象合规性要求 | | | | | 是否包括单独或者合计持有上市公司 5%以上股份的股东 ...

0 声明 证券代码：300575 证券简称：中旗股份 江苏中旗科技股份有限公司 2025 年限制性股票激励计划 （草案）摘要 二〇二五年四月 本公司及全体董事、监事保证本激励计划及摘要不存在虚假记载、误导性陈述或重 大遗漏，并对其真实性、准确性、完整性承担个别和连带的法律责任。 1 特别提示 一、本激励计划系依据《中华人民共和国公司法》、《中华人民共和国证券法》、 《上市公司股权激励管理办法》和其他有关法律、法规、规章、规范性文件，以及《江 苏中旗科技股份有限公司章程》制订。 二、本激励计划所采用的激励工具为第一类限制性股票，股票来源为公司向激励对 象定向发行的江苏中旗科技股份有限公司（以下简称"公司"或"上市公司"）A 股普通股 股票。 激励对象根据本激励计划获授的限制性股票在解除限售前均不得转让、用于担保或 偿还债务等。 三、本激励计划授予的激励对象总人数为 332 人，包括公司公告本激励计划时在公 司（含子公司,下同）任职的核心管理人员及核心技术（业务）人员。参与本激励计划的 激励对象不包括独立董事及单独或合计持有公司 5%以上股份的股东或实际控制人及其 配偶、父母、子女。 四、本激励计划拟授予的限制性 ...

江苏中旗科技股份有限公司 薪酬与考核委员会关于公司2025年限制性股票激励计划相关 事项的核查意见 江苏中旗科技股份有限公司（以下简称"公司"）于 2025 年 4 月 7 日召开了第四 届薪酬与考核委员会第二次会议，2025 年 4 月 11 日召开了第四届董事会第六次会 议和第四届监事会第五次会议，审议通过了《关于公司<2025 年限制性股票激励计 划（草案）>及其摘要的议案》等议案。根据《中华人民共和国公司法》（以下简称 "《公司法》"）《中华人民共和国证券法》（以下简称"证券法》"）《上市公司股权 激励管理办法》（以下简称"《管理办法》"）等有关法律、法规及规范性文件和《江 苏中旗科技股份有限公司章程》（以下简称"《公司章程》"）的规定，公司薪酬与 考核委员会对《2025 年限制性股票激励计划（草案）》（以下简称"本激励计划"） 及其他相关资料进行核查后，发表意见如下： 一、关于公司《2025 年限制性股票激励计划（草案）》及其摘要的核查意见 1、公司不存在《管理办法》等法律法规、规范性文件规定的禁止实施股权激励 计划的下列情形，具备实施股权激励计划的主体资格： （1）最近一个会计年度财务会计报告被注 ...

证券代码：300575 证券简称：中旗股份 江苏中旗科技股份有限公司 2025 年限制性股票激励计划 （草案） 二〇二五年四月 0 三、本激励计划授予的激励对象总人数为 332 人，包括公司公告本激励计划时在公 司（含子公司,下同）任职的核心管理人员及核心技术（业务）人员。参与本激励计划的 激励对象不包括独立董事及单独或合计持有公司 5%以上股份的股东或实际控制人及其 配偶、父母、子女。 四、本激励计划拟授予的限制性股票数量为 1,450 万股，占本激励计划草案公告时 公司股本总额 46,475.64 万股的 3.12%。其中首次授予 1,250 万股，约占本激励计划草案 公告时公司股本总额 46,475.64 万股的 2.69%，约占本激励计划拟授予总额的 86.21%； 预留授予 200 万股，约占本激励计划草案公告时公司股本总额 46,475.64 万股的 0.43%，约占本激励计划拟授予总额的 13.79%。预留授予部分的激励对象在本激励计划 经股东会审议通过后 12 个月内确定，超过 12 个月未明确激励对象的，预留权益失效。 预留激励对象的确定标准参照首次授予的标准确定。 截至本激励计划公告日，公 ...